Allogene Therapeutics Inc (ALLO)
3.48
+0.08
(+2.35%)
USD |
NASDAQ |
Apr 23, 10:06
Allogene Therapeutics Net Income (TTM): -327.26M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -327.26M |
| September 30, 2023 | -340.64M |
| June 30, 2023 | -362.47M |
| March 31, 2023 | -359.27M |
| December 31, 2022 | -340.41M |
| September 30, 2022 | -237.70M |
| June 30, 2022 | -232.74M |
| March 31, 2022 | -228.89M |
| December 31, 2021 | -182.05M |
| September 30, 2021 | -316.87M |
| June 30, 2021 | -304.88M |
| Date | Value |
|---|---|
| March 31, 2021 | -294.92M |
| December 31, 2020 | -316.38M |
| September 30, 2020 | -242.68M |
| June 30, 2020 | -227.22M |
| March 31, 2020 | -207.49M |
| December 31, 2019 | -184.59M |
| September 30, 2019 | -154.07M |
| June 30, 2019 | -146.84M |
| March 31, 2019 | -240.49M |
| December 31, 2018 | -211.50M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-362.47M
Minimum
Jun 2023
-146.84M
Maximum
Jun 2019
-263.55M
Average
-242.68M
Median
Sep 2020
Net Income (TTM) Benchmarks
| Agenus Inc | -245.76M |
| ANI Pharmaceuticals Inc | 18.78M |
| Vaxart Inc | -82.46M |
| aTyr Pharma Inc | -50.39M |
| PAVmed Inc | -64.18M |